Investors bought shares of Humana Inc (NYSE:HUM) on weakness during trading on Thursday. $227.56 million flowed into the stock on the tick-up and $120.03 million flowed out of the stock on the tick-down, for a money net flow of $107.53 million into the stock. Of all equities tracked, Humana had the 13th highest net in-flow for the day. Humana traded down ($8.20) for the day and closed at $316.27

A number of brokerages have issued reports on HUM. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $373.00 price target on the stock in a report on Thursday. Piper Jaffray Companies lifted their price objective on shares of Humana from $355.00 to $380.00 and gave the stock an “overweight” rating in a research note on Friday, August 24th. Argus lifted their price objective on shares of Humana to $375.00 and gave the stock a “buy” rating in a research note on Tuesday, September 4th. Barclays initiated coverage on shares of Humana in a research note on Thursday, September 13th. They issued an “overweight” rating and a $370.00 price objective for the company. Finally, Morgan Stanley lifted their price objective on shares of Humana from $400.00 to $418.00 and gave the stock a “buy” rating in a research note on Thursday, November 8th. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $352.10.

The company has a market capitalization of $44.51 billion, a P/E ratio of 23.24, a price-to-earnings-growth ratio of 1.54 and a beta of 0.99. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.68 and a current ratio of 1.68.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, November 7th. The insurance provider reported $4.58 EPS for the quarter, topping analysts’ consensus estimates of $4.29 by $0.29. Humana had a net margin of 2.70% and a return on equity of 19.10%. The firm had revenue of $14.21 billion during the quarter, compared to analysts’ expectations of $13.97 billion. During the same period in the previous year, the company earned $3.39 EPS. Analysts anticipate that Humana Inc will post 14.43 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Monday, December 31st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, December 28th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.63%. Humana’s dividend payout ratio is presently 11.96%.

In related news, CEO Bruce D. Broussard sold 18,000 shares of Humana stock in a transaction dated Monday, September 10th. The shares were sold at an average price of $328.66, for a total transaction of $5,915,880.00. Following the completion of the transaction, the chief executive officer now directly owns 71,085 shares of the company’s stock, valued at approximately $23,362,796.10. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Roy A. Beveridge sold 4,622 shares of Humana stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $341.06, for a total transaction of $1,576,379.32. Following the transaction, the insider now directly owns 10,621 shares of the company’s stock, valued at $3,622,398.26. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by insiders.

Several hedge funds have recently added to or reduced their stakes in the stock. Janney Montgomery Scott LLC boosted its position in Humana by 4.7% during the 2nd quarter. Janney Montgomery Scott LLC now owns 4,791 shares of the insurance provider’s stock worth $1,426,000 after acquiring an additional 213 shares during the period. Commonwealth Equity Services LLC boosted its position in Humana by 18.7% during the 2nd quarter. Commonwealth Equity Services LLC now owns 8,053 shares of the insurance provider’s stock worth $2,397,000 after acquiring an additional 1,269 shares during the period. Migdal Insurance & Financial Holdings Ltd. boosted its position in Humana by 2,984.6% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 401 shares of the insurance provider’s stock worth $119,000 after acquiring an additional 388 shares during the period. Smith Asset Management Group LP boosted its position in Humana by 4.4% during the 2nd quarter. Smith Asset Management Group LP now owns 109,050 shares of the insurance provider’s stock worth $32,457,000 after acquiring an additional 4,590 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in Humana by 425.8% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 24,975 shares of the insurance provider’s stock worth $7,433,000 after acquiring an additional 20,225 shares during the period. 92.90% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was reported by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/traders-buy-shares-of-humana-hum-on-weakness/2666726.html.

Humana Company Profile (NYSE:HUM)

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

See Also: Float

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.